Orca Bio Stock

orcabio.comBioTechFounded: 2016Funding to Date: $291.19MM

Orca Bio is the developer of high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Orca Bio, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Orca Bio investors also invested in these private companies

Team

Management Team

Ivan Dimov Ph.D
Co-Founder & Chief Executive Officer
Jeroen Bekaert
Chief Operating Officer
Nathaniel Fernhoff Ph.D
Co-Founder & Chief Science Officer
Dan Kirby
Chief Commercial Officer

Board Members

Alex Kolicich
8VC
Jonathan MacQuitty Ph.D
Lightspeed Venture Partners

Other companies like Orca Bio in the BioTech sector

Sector
Last Round Est. Valuation
$143.8MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$138.75MM
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$289.42MM
Sector
Last Round Est. Valuation
$1.08B